中文  English

Boao E-letter news

Pfizer Became the Leader of Genetic Therapies by Acquiring Bamboo Therapeutics

Time:2016-08-12 16:56:09    Views:146107    Origin:Boao Forum for Asia

Through this acquisition, Pfizer combined the genetic therapy product series, advanced carrier design, technology and capacity of Bamboo Therapeutics with its own global scale, R&D and business experience. 
 
Today Pfizer (NYSE:PFE) announced its acquisition of Bamboo Therapeutics. Bamboo Therapeutics is a privately held biotechnology company based in Chapel Hill, N.C. It is focused on developing gene therapies for the potential treatment of patients with certain rare diseases related to neuromuscular conditions and those affecting the central nervous system. 

Mikael Dolsten, President of Pfizer Worldwide Research & Development, said: “We believe that gene therapy may hold the promise of bringing true disease modification for patients suffering from catastrophic diseases, and we hope to see this promise come to fruition.